Sign in

You're signed outSign in or to get full access.

Eric Healy

Eric Healy

Chief Executive Officer at BranchOut Food
CEO
Executive
Board

About Eric Healy

Eric Healy, age 42, is Chief Executive Officer and Chairman of BranchOut Food (BOF) and has served as CEO since the company’s inception in November 2017. He holds a B.S. in Mechanical Engineering from Oregon State University and previously worked as a mechanical/product development engineer and food entrepreneur, including ownership of the No-Bake Cookie Company and engineering roles at Stratos, Synapse, and Boeing . Operational performance accelerated in 2025: Q3 revenue was approximately $3.2 million with YTD ~$9.7 million, up 93% YoY, and gross margin of 17% (closer to 30% excluding air shipments); production hit a $16 million annualized run rate in September, and October monthly revenue reached $1.7 million ($20 million annualized) . Board independence context: Healy is not independent under Nasdaq standards and serves as both CEO and Chairman, with no Lead Director, though independent directors comprise four of six board members .

Past Roles

OrganizationRoleYearsStrategic Impact
No-Bake Cookie CompanyOwner/PartnerNot disclosedRan all aspects of the company; food entrepreneur experience
Stratos Product DevelopmentSenior Mechanical EngineerNot disclosedConsumer product development; technical execution
Synapse Product DevelopmentSenior Mechanical EngineerNot disclosedConsumer product development; technical execution
Boeing CompanyMechanical EngineerNot disclosedEngineering foundation; process discipline

External Roles

  • No public company board service beyond BOF disclosed for Healy; no external committee roles disclosed .

Fixed Compensation

Multi-year CEO cash compensation (per Summary Compensation Table):

Metric20232024
Base Salary ($)$222,490 $255,377
Bonus ($)$100,000 (IPO completion bonus per employment agreement) $0
Option Awards ($ grant-date fair value)$0 $120,132 (Black-Scholes)
Total ($)$322,490 $375,509

Key fixed terms (per employment agreement dated Dec 6, 2022):

  • Base salary set at $250,000 annually (commencing upon IPO in June 2023) .
  • Annual bonus at board’s discretion; $100,000 bonus required upon IPO completion in 2023 .

Performance Compensation

  • Annual Bonus Program: | Metric | Weighting | Target | Actual | Payout | Vesting | |---|---|---|---|---|---| | Board-determined (no specific metrics disclosed) | Not disclosed | Not disclosed | 2023: IPO completion | 2023: $100,000; 2024: $0 | Cash; not subject to vesting |

  • Stock Options (Equity Incentives): | Grant Date | Type | Shares | Exercise Price | Expiration | Vesting/Status | Grant-Date Value | |---|---|---:|---:|---|---|---:| | Feb 22, 2024 | Stock Option | 140,000 | $1.92 | Feb 21, 2034 | Shown fully exercisable at 12/31/2024 (0 unexercisable) | $120,132 (Black-Scholes, vol 41%) |

Notes:

  • No RSUs/PSUs disclosed for Healy; option exercises/stock vesting: none by NEOs in 2024 .

Equity Ownership & Alignment

ItemDetail
Total Beneficial Ownership2,127,104 shares
Ownership % of Class16.1%
Options Exercisable140,000 @ $1.92, exp. 2/21/2034
Options Unexercisable0 (as of 12/31/2024)
Additional Warrants (Unit Offering)Participated in $400,000 of Units on 7/23/2024; each Unit included 100 shares + warrant to buy 125 shares at $1.00; warrants exercisable only upon stockholder approval per Nasdaq rules
Stock Ownership GuidelinesNot disclosed
Pledging/HedgingNo pledging disclosure; Code of Ethics covers insider trading generally
Section 16 ComplianceOne late Form 4 filing noted for Healy (and others) in FY2024

Employment Terms

TermDetails
Agreement DateDecember 6, 2022
RoleCEO and Chairman
Term LengthThree years from agreement date (used in severance formula)
Base Salary$250,000 annually (commenced upon June 2023 IPO)
Annual BonusDetermined by Board; $100,000 mandated upon IPO completion
Severance (involuntary termination w/o Cause or resignation for Good Reason)(x) Remaining unpaid amounts under employment term + (x) additional 12 months of then-current base salary (both payable on termination date); (y) target bonus for year of termination paid within 5 days; (z) continued medical/dental coverage; “Cause”/“Good Reason” defined in agreement
Non-Compete/Non-Solicit/Non-Disparagement24 months post-termination; confidentiality obligations apply
Change-of-ControlNot separately specified beyond severance mechanics; no single/double-trigger terms disclosed

Board Governance

  • Structure and Independence:

    • Board: six directors; Healy (CEO/Chairman) and CFO Dalfonsi are not independent; four independent directors (Jain, Jones, Schwartz, Somerville) .
    • Dual role: CEO also serves as Chairman; no Lead Director; Board may reassess structure in future .
  • Committees: | Committee | Members | Chair | |---|---|---| | Audit Committee | Jones, Schwartz, Somerville | Jones | | Compensation Committee | Schwartz, Somerville, Jones | Schwartz | | Nominating & Corporate Governance Committee | Jain, Somerville, Jones | Jain |

  • Audit Financial Expert:

    • Following Dalfonsi’s resignation from the Audit Committee in Jan 2024, no current member meets “audit committee financial expert” definition; company seeking candidate .
  • Board Activity/Attendance (historical):

    • 2023: no formal meetings; acted by unanimous written consent 11 times; no formal policy on annual meeting attendance .

Compensation Committee Analysis

  • Independence and Charter: All Compensation Committee members meet SEC/Nasdaq independence criteria; operates under a written charter available on the website .
  • Composition changes: 2024 committee chaired by David Israel; by 2025, chair role transitioned to Lindsey Schwartz following board changes .
  • Scope: Approves executive/director compensation and administers equity/cash plans .

Related Party Transactions (Alignment/Conflicts)

  • July 2024 Unit Offering: Healy ($400,000), Eagle Vision (affiliate of CFO) ($100,000), and President ($25,000) purchased Units (100 shares + warrant to buy 125 shares at $1.00, 10-year term); warrants require stockholder approval per Nasdaq Rules 5635(c)/(d); exercise would dilute existing holders .
  • Section 16(a) late filings: One late Form 4 for Healy (and others) in FY2024 .
  • Kaufman Kapital LLC: 34.5% ownership; board proposals in 2024 sought approval for conversion/exercise to maintain Nasdaq equity compliance, potentially constituting change of control; dilution risks disclosed .

Performance Compensation (Equity Details)

Category2024 Detail
Options Granted140,000 options @ $1.92; Black-Scholes value $120,132; volatility 41%
Options Outstanding (12/31/2024)140,000 exercisable; 0 unexercisable; expires 2/21/2034
Option Exercises/Vesting ActivityNo option exercises or stock vesting by NEOs during 2024

Say-on-Pay & Shareholder Feedback

  • 2025 Advisory Vote on Executive Compensation: Board unanimously recommends FOR approval; results not yet available (meeting Dec 30, 2025) .

Equity Plan Capacity (dilution context)

Plan CategorySecurities to be issued upon exerciseWeighted-average exercise priceAvailable for future issuance
Equity compensation plans approved by security holders593,470 $2.39 415,530
Equity comp plans not approved by security holders (underwriter warrants)182,735 $3.76 N/A
Total776,205 $2.71 415,530

Investment Implications

  • Pay-for-performance alignment: Cash comp is modest; equity mix relies on stock options (140k @ $1.92), creating upside alignment if execution drives scale and margins; absence of disclosed formulaic performance metrics for bonuses suggests discretionary elements, which may weaken direct alignment but is common in early-stage growth contexts .
  • Retention and severance economics: Severance is substantial—remaining unpaid term plus 12 months salary, target bonus, and benefits—indicating strong retention incentives but with potential shareholder cost if termination occurs; 24-month non-compete/non-solicit provides post-termination protection .
  • Insider selling pressure: No 2024 option exercises; high beneficial stake (16.1%) and participation in unit offering point to alignment, though future warrant exercises could introduce supply; one late Form 4 is a minor governance blemish .
  • Governance risk flags: CEO/Chair dual role with no Lead Director and audit committee lacking a financial expert elevate governance risk; however, majority-independent board and active committee structure mitigate some concerns .
  • Execution track record: Rapid operational scaling in 2025 (YTD revenue +93% YoY, run-rate progression from $16M to $20M) and margin pathway (17% reported; ~30% normalized excluding air freight) bolster the case for equity-linked compensation—and may reduce near-term selling pressure if growth persists .

Net: Healy’s sizable ownership, recent at-the-money option grant, and discretionary bonus framework point to alignment with growth objectives, but dual-role governance and committee expertise gaps should be monitored, alongside dilution from related-party and strategic financings aimed at maintaining Nasdaq compliance .